Filing Details

Accession Number:
0001628280-20-016822
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-25 16:02:46
Reporting Period:
2020-11-23
Accepted Time:
2020-11-25 16:02:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1213037 Cardiff Oncology Inc. CRDF Biological Products, (No Disgnostic Substances) (2836) 272004382
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1815809 Vicki Kelemen C/O Cardiff Oncology, Inc.
11055 Flintkote Ave
San Diego CA 92121
Exec. Vp And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-23 35,321 $2.48 40,375 No 4 M Direct
Common Stock Disposition 2020-11-23 35,321 $18.60 5,054 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2020-11-23 35,321 $2.48 35,321 $2.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
70,641 2029-06-20 No 4 M Direct
Footnotes
  1. The common stock was sold by the reporting person in a series of open market transactions on the transaction date at a weighted average sale price of $18.6014. The range of prices was $18.40 to $19.25. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares sold at each price.
  2. 35,321 options vested on 6/20/2020.